FR12C0060I2 - PROCESS FOR MANUFACTURING VACCINES - Google Patents

PROCESS FOR MANUFACTURING VACCINES

Info

Publication number
FR12C0060I2
FR12C0060I2 FR12C0060C FR12C0060C FR12C0060I2 FR 12C0060 I2 FR12C0060 I2 FR 12C0060I2 FR 12C0060 C FR12C0060 C FR 12C0060C FR 12C0060 C FR12C0060 C FR 12C0060C FR 12C0060 I2 FR12C0060 I2 FR 12C0060I2
Authority
FR
France
Prior art keywords
manufacturing vaccines
vaccines
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR12C0060C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0513071.1A external-priority patent/GB0513071D0/en
Priority claimed from GB0515556A external-priority patent/GB0515556D0/en
Priority claimed from GB0524204A external-priority patent/GB0524204D0/en
Priority claimed from GB0526040A external-priority patent/GB0526040D0/en
Priority claimed from GB0526041A external-priority patent/GB0526041D0/en
Priority claimed from PCT/EP2006/006270 external-priority patent/WO2007000343A2/en
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of FR12C0060I1 publication Critical patent/FR12C0060I1/fr
Application granted granted Critical
Publication of FR12C0060I2 publication Critical patent/FR12C0060I2/en
Active legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
FR12C0060C 2005-06-27 2012-10-18 PROCESS FOR MANUFACTURING VACCINES Active FR12C0060I2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB0513071.1A GB0513071D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
GBGB0513069.5A GB0513069D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
GB0515556A GB0515556D0 (en) 2005-07-28 2005-07-28 Immunogenic composition
GB0524204A GB0524204D0 (en) 2005-11-28 2005-11-28 Immunogenic composition
GB0526040A GB0526040D0 (en) 2005-12-21 2005-12-21 Immunogenic composition
GB0526041A GB0526041D0 (en) 2005-12-21 2005-12-21 Immunogenic composition
PCT/EP2006/006270 WO2007000343A2 (en) 2005-06-27 2006-06-23 Process for manufacturing vaccines

Publications (2)

Publication Number Publication Date
FR12C0060I1 FR12C0060I1 (en) 2012-12-14
FR12C0060I2 true FR12C0060I2 (en) 2017-01-06

Family

ID=34856207

Family Applications (1)

Application Number Title Priority Date Filing Date
FR12C0060C Active FR12C0060I2 (en) 2005-06-27 2012-10-18 PROCESS FOR MANUFACTURING VACCINES

Country Status (7)

Country Link
CN (4) CN101208103B (en)
ES (1) ES2367918T5 (en)
FR (1) FR12C0060I2 (en)
GB (1) GB0513069D0 (en)
NO (1) NO2021022I1 (en)
UA (1) UA97233C2 (en)
ZA (3) ZA200710853B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201900778T4 (en) * 2012-01-30 2019-02-21 Serum Institute Of India Private Ltd Immunogenic composition.
RU2645071C2 (en) * 2012-08-16 2018-02-15 Пфайзер Инк. Methods of glycogonjugation and composition
BE1025443B1 (en) * 2016-11-25 2019-02-28 Glaxosmithkline Biologicals Sa NOMV-ANTIGEN CONJUGATES AND THEIR USE
CN109879967A (en) * 2017-12-15 2019-06-14 苏州和锐生物科技有限公司 A kind of preparation method and application of acetylglucosamine conjugate
CN110251667A (en) * 2018-05-11 2019-09-20 武汉博沃生物科技有限公司 A kind of immune combination preparation and its preparation method and application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180815A (en) * 1988-04-13 1993-01-19 Fuji Photo Film Co., Ltd. Modified protein for carrying hapten
NZ523319A (en) * 2000-06-29 2006-01-27 Glaxosmithkline Biolog Sa Vaccine compositions comprising Pw, TT, DT and H. influenzae type B (Hib) with a lower dose of Hib (5 mcg) compared with the standard does (10 mcg)
CN1558773A (en) * 2001-04-06 2004-12-29 巴斯德研究院 Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of vibrio cholerae O139 bound to tetanus toxoid
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
CN1401328A (en) * 2002-10-18 2003-03-12 北京绿竹生物技术有限责任公司 Epidemic meningitis polyose-protein binding vaccine
EP2172213B1 (en) * 2003-01-30 2013-04-03 Novartis AG Injectable vaccines against multiple meningococcal serogroups

Also Published As

Publication number Publication date
ES2367918T5 (en) 2014-11-21
UA97233C2 (en) 2012-01-25
FR12C0060I1 (en) 2012-12-14
CN101208101A (en) 2008-06-25
CN101208103B (en) 2013-04-24
CN101208101B (en) 2013-01-02
ZA200710909B (en) 2009-04-29
CN101222935B (en) 2015-07-29
ES2367918T3 (en) 2011-11-10
GB0513069D0 (en) 2005-08-03
ZA200711074B (en) 2009-07-29
CN101208103A (en) 2008-06-25
CN101222935A (en) 2008-07-16
NO2021022I1 (en) 2021-05-25
CN101247827B (en) 2013-07-17
ZA200710853B (en) 2009-04-29
CN101247827A (en) 2008-08-20

Similar Documents

Publication Publication Date Title
HUS1200023I1 (en) Process for manufacturing vaccines
GB0700136D0 (en) Process for manufacturing vaccines
FR2902785B1 (en) PROCESS FOR PRODUCING 1,2-DICHLOROETHANE
FR2870231B1 (en) PROCESS FOR PRODUCING GLASS CERAMIC
PL1923359T3 (en) Process for producing vials
FR2903983B1 (en) PROCESS FOR PRODUCING DIESTERS
FR2902787B1 (en) PROCESS FOR PRODUCING 1,2-DICHLOROETHANE
FR2902786B1 (en) PROCESS FOR PRODUCING 1,2-DICHLOROETHANE
DE602006020716D1 (en) BOX-FREE SHAPING PROCESS
FR2902784B1 (en) PROCESS FOR PRODUCING 1,2-DICHLOROETHANE
DE602006004399D1 (en) grinding process
FR2930457B1 (en) PROCESS FOR MANUFACTURING RECONFIGURABLE MICROCHANNELS
FR2922887B1 (en) IMPROVED METHOD OF MANUFACTURING DIESTERS.
FR2895286B1 (en) MILLING PROCESS
FR12C0060I2 (en) PROCESS FOR MANUFACTURING VACCINES
FR2908423B1 (en) BEER MANUFACTURING PROCESS
FR2894958B1 (en) PROCESS FOR THE PREPARATION OF DIFLUOROETHANOL
FR2876998B1 (en) PROCESS FOR PREPARING GAMMA-LIV205
FR2865480B1 (en) PROCESS FOR PRODUCING NON-WOVEN SURFACES
FR2884686B1 (en) HERBICIDE PROCESS
FR2902788B1 (en) PROCESS FOR PRODUCING PENTAFLUOROETHANE
FR2901788B1 (en) PROCESS FOR PRODUCING PENTAFLUOROETHANE
ATE427413T1 (en) CONDENSATION PROCESS
FR2909558B1 (en) PROCESS FOR PRODUCING MEDICAMENT PREMISES
FR2901789B1 (en) PROCESS FOR PRODUCING HYDROFLUOROCARBONS